Upstream Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Upstream Bio Inc (UPB)
Track the Upstream Bio share price today and view real-time UPB share price data, including charts, technicals, and key financials. View the UPB premarket stock price ahead of the market session or assess the after hours quote. Explore UPB stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Upstream Bio Stock Price Today?
The Upstream Bio stock price today is 5.17.
What Is the Stock Symbol for Upstream Bio?
The stock symbol for Upstream Bio is ""UPB.""
What Stock Exchange Does Upstream Bio Trade On?
Upstream Bio is listed and trades on the NASDAQ stock exchange.
Is Upstream Bio a Good Stock to Buy?
Determining whether Upstream Bio or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the UPB quote. (ISIN: US91678A1079)
What Is the Upstream Bio Stock Price Today?
The Upstream Bio stock price today is 5.17.
What Is the Stock Symbol for Upstream Bio?
The stock symbol for Upstream Bio is ""UPB.""
What Stock Exchange Does Upstream Bio Trade On?
Upstream Bio is listed and trades on the NASDAQ stock exchange.
Is Upstream Bio a Good Stock to Buy?
Determining whether Upstream Bio or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the UPB quote. (ISIN: US91678A1079)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.05
5.20
52 wk Range
4.99
33.68
UPB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.055.20
52 wk Range
4.9933.68
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
UPB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
31.14
Upside
+502.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Upstream Bio receives Investment Bank Analyst Rating Update- Investing.com
Pro
Upstream Bio receives Investment Bank Analyst Rating Update- Investing.com
Pro
Form 8K Upstream Bio Inc For: 11 August- Investing.com
- Upstream Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Upstream Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Upstream Bio Inc For: 11 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 31.14
(+502.38% Upside)
Earnings
Latest Release
11/08/2026
EPS / Forecast
-0.73 / -0.89
Revenue / Forecast
773K / --
Compare UPB to Peers and Sector
Metrics to compare | UPB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipUPBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −1.0x | −0.4x | |
PEG Ratio | −0.39 | −0.02 | 0.00 | |
Price/Book | 1.0x | 3.5x | 2.6x | |
Price / LTM Sales | 89.7x | 14.4x | 3.1x | |
Upside (Analyst Target) | - | 78.8% | 55.6% | |
Fair Value Upside | Unlock | 17.7% | 7.8% | Unlock |
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Upstream Bio (UPB) Stock Price Today?
The Upstream Bio stock price today is 5.17 USD.
What Stock Exchange Does Upstream Bio Trade On?
Upstream Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Upstream Bio?
The stock symbol for Upstream Bio is "UPB."
What Is the Upstream Bio Market Cap?
As of today, Upstream Bio market cap is 284.26M USD.
What Is Upstream Bio's Earnings Per Share (TTM)?
The Upstream Bio EPS (TTM) is -2.89.
When Is the Next Upstream Bio Earnings Date?
Upstream Bio will release its next earnings report on 05/11/2026.
From a Technical Analysis Perspective, Is UPB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Upstream Bio Stock Split?
Upstream Bio has split 0 times.
How Many Employees Does Upstream Bio Have?
Upstream Bio has 75 employees.
What is the current trading status of Upstream Bio (UPB)?
As of 24/09/2026, Upstream Bio (UPB) is trading at a price of 5.17 USD, with a previous close of 5.19 USD. The stock has fluctuated within a day range of 5.05 USD to 5.20 USD, while its 52-week range spans from 4.99 USD to 33.68 USD.
What Is Upstream Bio (UPB) Price Target According to Analysts?
The average 12-month price target for Upstream Bio is 31.14 USD, with a high estimate of 75 USD and a low estimate of 9 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +502.38% Upside potential.
What Is the UPB Premarket Price?
UPB's last pre-market stock price is 5.24 USD. The pre-market share volume is 2,400.00, and the stock has decreased by 0.05, or 0.96%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.